Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
three-generation reproductive toxicity
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1970-06-12 to 1971-10-13
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with generally accepted scientific standards and described in sufficient detail

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1971
Report date:
1971

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
The three-generation reproduction study was performed in 1971; there was no test guideline for such test available at that time.
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Reference substance name:
Decanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt
Cas Number:
13557-74-9
IUPAC Name:
Decanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 12A 5022

Test animals

Species:
rat
Strain:
Sprague-Dawley
Details on species / strain selection:
albino
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc.
- Females (if applicable) nulliparous and non-pregnant: Yes
- Age at study initiation: Day 28
- Fasting Period Prior to Study: No
- Housing: Individually housed prior to study
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 7 days

Administration / exposure

Route of administration:
oral: feed
Vehicle:
unchanged (no vehicle)
Details on exposure:
DIET PREPARATION
- Rate of preparation of diet (frequency): once
- Mixing appropriate amounts with (Type of food): The experimental diets were prepared by grinding appropriate amounts of the test material with a small quantity of the basal ration (Purina Laboratory Chow-Meal) in a mortar and pestle and mixing the resultant blend in a Hobart-Dayton mixer with enough basal ration to make a 6000-g batch of the desired concentration. All diets were fortified with USP cod liver oil at a concentration of 1%
Details on mating procedure:
- M/F ratio per cage: 1 M/1 F
- Length of cohabitation: 10 day
- Proof of pregnancy: Not specified
Duration of treatment / exposure:
Day 28 of F0 generation - end of study (weaning of F3 pups)
Frequency of treatment:
Daily
Details on study schedule:
Original parent rats (F0) were bred twice; the F1A pups were sacrificed at birth and part of each litter was examined either for skeletal abnormalities or for visceral changes. F1B pups were reared to weaning and pups from each litter were taken to constitute the next group of breeders. F1B rats were bred twice, and both F2A and F2B litters were reared to weaning. F2B pups were then distributed into new groups to breed the F3 generations.
Doses / concentrations
Dose / conc.:
20 000 ppm
Remarks:
Diet containing 2% of sodium stearoyl lactylate.

However, during the first six weeks of the study, rats were fed 60% of these concentrations as they eat more in proportion to body weight than subsequently.
No. of animals per sex per dose:
20
Control animals:
yes
Positive control:
none

Examinations

Parental animals: Observations and examinations:

CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Daily

BODY WEIGHT: Yes
- Time schedule for examinations: Weekly, Time of sacrifice

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Mean weekly food intake measured
Oestrous cyclicity (parental animals):
Not mentioned
Sperm parameters (parental animals):
Not mentioned
Litter observations:
PARAMETERS EXAMINED
The following parameters were examined in all offspring:
number and sex of pups, stillbirths, live births, presence of gross anomalies, weight gain

GROSS EXAMINATION OF DEAD PUPS:
Yes
Postmortem examinations (parental animals):
SACRIFICE
- Male animals: All surviving animals after offspring weaned.
- Maternal animals: All surviving animals after offspring weaned.

GROSS NECROPSY
- Gross necropsy consisted of gonad weights and litter data.

HISTOPATHOLOGY / ORGAN WEIGHTS
Gonad weights
Postmortem examinations (offspring):

GROSS NECROPSY
- Gross necropsy consisted of gonad weights and litter data.

HISTOPATHOLOGY / ORGAN WEIGHTS
- Gonad weights (i.e. testes in males and ovary in females) in all parent and foetal generations
- Heart, liver and kidney weights of F3 generations (occurred two days after weaning of F3 pups)
- Histopathology of F3 generations
Statistics:
not specified
Reproductive indices:
Testis weights in males
Ovary weights and implantation sites in females
Days of gestation
Offspring viability indices:
Numbe rof live/dead pups per litter

Results and discussion

Results: P0 (first parental generation)

General toxicity (P0)

Clinical signs:
no effects observed
Description (incidence and severity):
All P0 rats survived their portion of the study and were in good condition throughout.
Dermal irritation (if dermal study):
not examined
Mortality:
no mortality observed
Description (incidence):
All P0 rats survived their portion of the study and were in good condition throughout.
Body weight and weight changes:
no effects observed
Description (incidence and severity):

At 19-20 weeks of study the treated P0 rats of either sex weighed 94-99% as much as the controls.
Food consumption and compound intake (if feeding study):
no effects observed
Description (incidence and severity):
The mean food consumption paralleled body weights.
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Behaviour (functional findings):
not examined
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
no effects observed
Histopathological findings: non-neoplastic:
not examined
Histopathological findings: neoplastic:
not examined

Reproductive function / performance (P0)

Reproductive function: oestrous cycle:
not examined
Reproductive function: sperm measures:
not examined
Reproductive performance:
no effects observed
Description (incidence and severity):
The uterine implantation sites between treated and control female rats were comparable to one another. There was no significant differences observed in the number of gestation days between control (range of 21-22 days) and treated (range of 21 to 24 days) dams.

Effect levels (P0)

Dose descriptor:
NOEL
Effect level:
20 000 ppm
Sex:
male/female
Basis for effect level:
clinical signs
mortality
body weight and weight gain
food consumption and compound intake
organ weights and organ / body weight ratios
gross pathology
reproductive performance

Target system / organ toxicity (P0)

Critical effects observed:
no

Results: P1 (second parental generation)

General toxicity (P1)

Clinical signs:
no effects observed
Description (incidence and severity):
All P1 rats survived their portion of the study and were in good condition throughout.
Dermal irritation (if dermal study):
not examined
Mortality:
no mortality observed
Description (incidence):
All P1 rats survived their portion of the study and were in good condition throughout.
Body weight and weight changes:
no effects observed
Description (incidence and severity):
At week 22 the males and females receiving the material in the diet weighed 91 and 103 per cent as much, respectively, as the controls.
Food consumption and compound intake (if feeding study):
no effects observed
Description (incidence and severity):
Food consumptions figures for the two groups were closely similar throughout the experiment.
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Behaviour (functional findings):
not examined
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
no effects observed
Description (incidence and severity):
The gonadal weights between treated and control groups were comparable to one another.
Gross pathological findings:
no effects observed
Description (incidence and severity):
At necropsy the P1 parents showed no gross abnormalities.
Neuropathological findings:
not examined
Histopathological findings: non-neoplastic:
not specified
Histopathological findings: neoplastic:
not examined
Other effects:
not examined

Reproductive function / performance (P1)

Reproductive function: oestrous cycle:
not examined
Reproductive function: sperm measures:
not examined
Reproductive performance:
no effects observed
Description (incidence and severity):
Mean testis and ovary weights and mean total uterine implantation sites were respectively comparable among the groups. No meaningful discrepancies between total numbers of implantation sites and total numbers of pups per dam were found.

Effect levels (P1)

Key result
Dose descriptor:
NOEL
Effect level:
20 000 ppm
Based on:
test mat.
Sex:
male/female
Basis for effect level:
clinical signs
mortality
body weight and weight gain
food consumption and compound intake
organ weights and organ / body weight ratios
gross pathology
reproductive performance

Target system / organ toxicity (P1)

Key result
Critical effects observed:
no

Results: F1 generation

General toxicity (F1)

Clinical signs:
no effects observed
Description (incidence and severity):
Slightly lower survival at five and twenty-one days which is believed to be happenstance, and the fact the survival at weaning in this group was somewhat superior to control weanling survival also indicates that compound feeding was not responsible.
Dermal irritation (if dermal study):
not examined
Mortality / viability:
mortality observed, non-treatment-related
Description (incidence and severity):
Slightly lower survival at five and twenty-one days which is believed to be happenstance, and the fact the survival at weaning in this group was somewhat superior to control weanling survival also indicates that compound feeding was not responsible.
Body weight and weight changes:
no effects observed
Description (incidence and severity):
At week 22 the males and females receiving the material in the diet weighed 91 and 103 per cent as much, respectively, as the controls.
Food consumption and compound intake (if feeding study):
no effects observed
Description (incidence and severity):
Food consumptions figures for the two groups were closely similar throughout the experiment.
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Sexual maturation:
not examined
Organ weight findings including organ / body weight ratios:
no effects observed
Description (incidence and severity):
The gonadal weights between treated and control groups were comparable to one another.
Gross pathological findings:
no effects observed
Description (incidence and severity):
At necropsy the F1 generation showed no gross abnormalities. Skeletal and visceral anomalies in sacrificed pups were not in frequencies high enough to be meaningful.
Histopathological findings:
not examined
Other effects:
not examined

Developmental neurotoxicity (F1)

Behaviour (functional findings):
not examined

Developmental immunotoxicity (F1)

Developmental immunotoxicity:
not examined

Effect levels (F1)

Key result
Dose descriptor:
NOAEL
Generation:
F1
Effect level:
20 000 ppm
Based on:
test mat.
Sex:
male/female
Basis for effect level:
viability
clinical signs
mortality
body weight and weight gain
food consumption and compound intake
organ weights and organ / body weight ratios
gross pathology

Target system / organ toxicity (F1)

Key result
Critical effects observed:
no

Results: F2 generation

General toxicity (F2)

Clinical signs:
no effects observed
Description (incidence and severity):
The F2 generation rats were in good condition. Slightly lower survival at five and twenty-one days which is believed to be because of an intercurrent infection of undetermined nature.
Dermal irritation (if dermal study):
not examined
Mortality / viability:
mortality observed, non-treatment-related
Description (incidence and severity):
Slightly lower survival at five and twenty-one days which is believed to be because of an intercurrent infection of undetermined nature.
Body weight and weight changes:
no effects observed
Description (incidence and severity):
At week 20 the males and females receiving the material in the diet weighed 93 to 99 per cent as much, respectively, as the controls.
Food consumption and compound intake (if feeding study):
no effects observed
Description (incidence and severity):
No significant differences were noted for food consumption.
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Sexual maturation:
not examined
Organ weight findings including organ / body weight ratios:
no effects observed
Description (incidence and severity):
The gonadal weights between treated and control groups were comparable to one another.
Gross pathological findings:
no effects observed
Description (incidence and severity):
No significant differences were shown between control and test rats. Stillborn pups examined in the group that received test material were grossly normal. Pups that died by day 5 and were in condition suitable for examination were also found to be grossly normal.
Histopathological findings:
not examined
Other effects:
not examined

Developmental neurotoxicity (F2)

Behaviour (functional findings):
not examined

Developmental immunotoxicity (F2)

Developmental immunotoxicity:
not examined

Effect levels (F2)

Key result
Dose descriptor:
NOAEL
Generation:
F2
Effect level:
20 000 ppm
Based on:
test mat.
Sex:
male/female
Basis for effect level:
viability
clinical signs
mortality
body weight and weight gain
food consumption and compound intake
organ weights and organ / body weight ratios
gross pathology

Target system / organ toxicity (F2)

Key result
Critical effects observed:
no

Overall reproductive toxicity

Key result
Reproductive effects observed:
no

Any other information on results incl. tables

There were no other significant differences or effects observed for mortality, body weights, food intake, gross necropsy (gonad weights) in either of the P2 or F3 generations.

None of the histopathological observations made in F3 generation were believed to be related to the administration of the test substance sodium capryl lactylate under the conditions of this study other than the questionable significance of the cortical cyst incidence in the kidneys of females.

 

The full tables of litter data for each generation are below.

F1A Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

18/20

17/20

Total live pups

207

177

Total Stillborn

1

1

Live pups per litter

11.5

10.4

Mean body weights (g) of live pups

5.53

5.64

Number of male pups

109

90

Number of female pups

98

87

 

F1B Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

12/20

12/20

Total live pups

 

 

     Birth

151

125

     Day 5

96

62

     Weaning

79

53

Total Stillborn

0

1

Live pups per litter

12.6

10.4

Per cent survival at day 5

63.6

49.6

100X weaning survival/ 5 day survival

86.8

93.0

Mean body weights (g) of live pups at

 

 

    Birth

5.90

6.02

    Day 5

9.65

9.18

    Weaning

41.5

32.8

 

F2A Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

19/19

19/20

Total live pups

 

 

     Birth

221

212

     Day 5

127

108

     Weaning

81

74

Total Stillborn

1

2

Live pups per litter

11.6

11.2

Per cent survival at day 5

57.5

50.9

100X weaning survival/ 5 day survival

68.6

71.9

Mean body weights (g) of live pups at

 

 

    Birth

5.96

6.10

    Day 5

7.43

7.69

    Weaning

33.9

34.0

 

F2B Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

17/19

20/20

Total live pups

 

 

     Birth

210

233

     Day 5

97

89

     Weaning

63

68

Total Stillborn

0

1

Live pups per litter

12.4

11.6

Per cent survival at day 5

46.2

38.2

100X weaning survival/ 5 day survival

72.4

78.2

Mean body weights (g) of live pups at

 

 

    Birth

5.91

5.91

    Day 5

8.34

77.76

    Weaning

39.5

32.0

 

F3A Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

14/20

18/20

Total live pups

 

 

     Birth

143

199

     Day 5

82

164

     Weaning

68

147

Total Stillborn

0

1

Live pups per litter

10.2

11.1

Per cent survival at day 5

57.6

82.4

100X weaning survival/ 5 day survival

82.9

89.6

Mean body weights (g) of live pups at

 

 

    Birth

5.73

5.72

    Day 5

8.89

8.57

    Weaning

37.5

33.1

 

F3B Litter Information

Observations

Control

Sodium Capryl Lactylate (2%)

Litters per group

16/20

17/20

Total live pups

 

 

     Birth

167

198

     Day 5

115

123

     Weaning

101

97

Total Stillborn

1

1

Live pups per litter

11.1

11.6

Per cent survival at day 5

68.9

62.1

100X weaning survival/ 5 day survival

87.8

78.6

Mean body weights (g) of live pups at

 

 

    Birth

6.03

5.90

    Day 5

9.76

8.20

    Weaning

36.7

33.4

 

Applicant's summary and conclusion

Conclusions:
There were no differences among control group and those fed sodium capryl lactylate that could be ascribed to treatment. Sodium stearoyl lactylate does not adversely effect reproduction in albino rats through three generations. The author noted there was a questionable significance of cortical cyst incidence in the kidneys of females.
Executive summary:

A three generation reproductive study in albino Sprague-Dawley Rats was performed on the test substance sodium capryl lactylate. Mortality, body weights, food intake, gross necropsy (gonad weights) and litter data were collected. There were no differences among control group and those fed sodium capryl lactylate that could be ascribed to treatment. The author noted there was a questionable significance of cortical cyst incidence in the kidneys of F3 females. Sodium capryl lactylate does not adversely effect reproduction in albino rats through three generations.